Eating Within a Window: How Time-Restricted Feeding Keeps Aging Arteries Young

When the 17th-century physician Thomas Sydenham declared that a man is as old as his arteries, he captured a truth that modern cardiology has only deepened: the gradual stiffening, thickening, and inflammation of blood vessels is one of the most reliable harbingers of the diseases that shorten human lives. Hypertension, stroke, and even Alzheimer’s disease all trace back, at least in part, to vascular aging. Now a new study published in Aging Cell suggests that one of the simplest dietary interventions available—confining eating to a narrow daily window—can slow this process dramatically, and that the secret lies not in the food itself but in the trillions of microbes that digest it.

Researchers at Wuhan Tongji Hospital set out to test whether time-restricted feeding, or TRF, could delay vascular aging in mice. The regimen they chose was demanding by human standards: animals had access to food for only six hours each day, aligned with their nocturnal circadian rhythm, while water remained freely available. Crucially, the mice did not lose weight. Caloric intake, body weight, fasting blood glucose, and fat mass were all essentially unchanged between the restricted eaters and mice eating whenever they pleased. Whatever benefit TRF conferred, it was not a simple consequence of eating less.

To model vascular aging, the team implanted pumps that delivered angiotensin II, a hormone that at sustained elevated levels drives hypertension, vascular wall thickening, elastic fiber fragmentation, and collagen deposition—a constellation of changes that mirrors what happens to human arteries over decades. After four weeks of infusion, mice on a normal diet showed markedly elevated systolic, diastolic, and mean blood pressure, along with increased pulse wave velocity, the gold-standard clinical measure of arterial stiffness. Their aortas dilated, their intima-media thickness increased, and their vascular walls showed the disorganized collagen and degraded elastic fibers characteristic of aged vessels under the electron microscope.

The restricted-fed mice told a strikingly different story. TRF significantly blunted the angiotensin II–induced rise in blood pressure, reduced aortic stiffness, and preserved the structural integrity of the vessel wall. At the molecular level, the intervention suppressed the upregulation of p53, p21, and p16—canonical markers of cellular senescence—in the aorta. The heart benefited as well: echocardiography showed better ejection fraction and fractional shortening, and histology revealed less myocardial fibrosis and cardiomyocyte hypertrophy, suggesting that TRF interrupts the vicious feedback loop in which stiff arteries strain the heart and a failing heart further damages the vasculature.

But the most provocative findings came from the gut. Metagenomic sequencing of fecal samples revealed that TRF reshaped the microbial community, increasing Firmicutes abundance and stabilizing the ratio of Firmicutes to Bacteroidetes, a microbial signature previously associated with aging resilience. When angiotensin II disrupted the microbiota of normally fed mice—depleting Bacteroidetes and enriching Verrucomicrobia—the restricted-fed animals maintained a stable community. TRF also protected the intestinal barrier: goblet cell numbers and mucus reserves were restored, tight junction proteins such as occludin, ZO-1, and MUC2 were preserved, and serum levels of lipopolysaccharide, a pro-inflammatory endotoxin that leaks into circulation when the gut lining fails, were significantly lower.

To prove that these microbial changes were not merely a byproduct of the diet but its actual cause, the researchers turned to germ-free mice. These animals, raised in sterile isolation and lacking any microbiome of their own, received fecal transplants from either normally fed or time-restricted donors. Remarkably, germ-free mice colonized with the TRF microbiota were resistant to angiotensin II–induced hypertension, vascular stiffening, aortic dilation, and pathological cardiac remodeling—despite never having been on the diet themselves. Their endothelium-dependent vasodilation, a key indicator of vascular health, was preserved where transplant recipients of normal microbiota lost it. The gut microbes alone were sufficient to carry the protection.

Metabolomic analysis pointed to the chemical messenger responsible. Fecal levels of short-chain fatty acids—microbial fermentation products known to reinforce barrier integrity, regulate blood pressure, and suppress inflammation—were elevated in the TRF-transplanted animals, with acetic acid showing the largest and most consistent increase. Correlation analyses strengthened the case: fecal acetic acid concentrations tracked positively with colonic tight junction protein expression and negatively with aortic senescence markers, pulse wave velocity, and cardiac fibrosis. Integrated metagenomic and metabolomic data further showed that TRF restored the abundance of genes in acetic acid synthesis pathways, and identified Limosilactobacillus, a lactic acid bacterium, as the key source organism enriched by the feeding schedule.

To test whether acetic acid could substitute for the diet itself, the team gave mice daily sodium acetate gavage alongside angiotensin II infusion. The supplement reproduced nearly all of TRF’s benefits: lower blood pressure, reduced aortic stiffness and dilation, less elastic fiber fragmentation and collagen deposition, improved cardiac function, and a fortified intestinal barrier with restored goblet cells and tight junctions. Conversely, when the researchers wiped out the microbiome with an antibiotic cocktail, TRF’s protective effects on vessels, heart, and gut largely vanished—yet supplementing acetate in these microbe-depleted animals restored blood pressure homeostasis and barrier integrity even though it could not rebuild the microbial community itself. Acetic acid, in other words, sits downstream of the microbiota and is sufficient to carry the signal.

The molecular mechanism traces an elegant path from bacterial metabolite to chromatin. Acetic acid engages GPR43, a G protein–coupled receptor on vascular and cardiac cells, which in turn suppresses the histone deacetylase HDAC3. With HDAC3 held in check, acetylation of histone H4 at lysine 8 rises, opening chromatin in a way that dampens the NLRP3 inflammasome and the pyroptotic cell death pathway it drives, along with the inflammatory cytokines TNF-α, IL-6, and IL-1β. In human umbilical vein endothelial cells exposed to angiotensin II, sodium acetate reversed the senescent phenotype, reduced senescence-associated beta-galactosidase positivity, and restored H4K8 acetylation—confirming that the axis operates in human-relevant cells, not just mouse tissue.

The authors are candid about the study’s limits. All experiments used male mice, leaving open whether females respond similarly given known sex differences in both vascular biology and gut ecology. The angiotensin II model, while well established, captures an accelerated form of vascular aging rather than the slow, multifactorial decline of natural aging, and validation in naturally aged animals is needed. Translating the schedule to humans is also nontrivial: a six-hour feeding window in mice, with their high metabolic rate and shifted circadian phase, roughly corresponds to an eight-to-ten-hour eating window in people, which may still be difficult for elderly patients managing medications, comorbidities, or malnutrition risk. Careful monitoring for hypoglycemia and muscle loss would be essential. Yet the core message stands as one of the most mechanistically complete demonstrations yet that a dietary pattern can slow cardiovascular aging through a defined microbe–metabolite–epigenome pathway. If the findings hold in human trials, the humble gut bacterium and its acidic byproduct may become targets for keeping arteries young—no calorie counting required.

Subject of Research: Time-restricted feeding, gut microbiota remodeling, and acetic acid-mediated delay of cardiovascular aging

Article Title: Time‐Restricted Feeding Delays Cardiovascular Aging by Increasing Acetic Acid Through Remodeling Gut Microbiota

Article References: Liu, M., Luo, M., Huang, Y., Ji, T., Wang, Y., Wang, Q., Huang, J., Jiang, T., Zhang, C., Mi, T., & Cheng, M. (2026). Time‐Restricted Feeding Delays Cardiovascular Aging by Increasing Acetic Acid Through Remodeling Gut Microbiota. Aging Cell, 25(10), Article e70728. https://doi.org/10.1111/acel.70728

Image Credits: AI Generated

DOI: 10.1111/acel.70728

Keywords: time-restricted feeding, vascular aging, gut microbiota, acetic acid, short-chain fatty acids, hypertension, Limosilactobacillus, GPR43, HDAC3, NLRP3 inflammasome, fecal microbiota transplantation, intestinal barrier